DK2931275T3 - Aclidinium til anvendelse i øgning af fysisk aktivitet i hverdagen hos en patient, der lider af kronisk, obstruktiv lungesygdom - Google Patents

Aclidinium til anvendelse i øgning af fysisk aktivitet i hverdagen hos en patient, der lider af kronisk, obstruktiv lungesygdom Download PDF

Info

Publication number
DK2931275T3
DK2931275T3 DK13805376.4T DK13805376T DK2931275T3 DK 2931275 T3 DK2931275 T3 DK 2931275T3 DK 13805376 T DK13805376 T DK 13805376T DK 2931275 T3 DK2931275 T3 DK 2931275T3
Authority
DK
Denmark
Prior art keywords
aclidinium
pulmonary disease
chronic obstructive
obstructive pulmonary
patient suffering
Prior art date
Application number
DK13805376.4T
Other languages
Danish (da)
English (en)
Inventor
Gil Maria Esther Garcia
Fernandez Diana Jarreta
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Application granted granted Critical
Publication of DK2931275T3 publication Critical patent/DK2931275T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK13805376.4T 2012-12-17 2013-12-13 Aclidinium til anvendelse i øgning af fysisk aktivitet i hverdagen hos en patient, der lider af kronisk, obstruktiv lungesygdom DK2931275T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12382507 2012-12-17
US201361750952P 2013-01-10 2013-01-10
PCT/EP2013/076606 WO2014095663A1 (en) 2012-12-17 2013-12-13 New use of aclidinium

Publications (1)

Publication Number Publication Date
DK2931275T3 true DK2931275T3 (da) 2022-07-04

Family

ID=47458806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13805376.4T DK2931275T3 (da) 2012-12-17 2013-12-13 Aclidinium til anvendelse i øgning af fysisk aktivitet i hverdagen hos en patient, der lider af kronisk, obstruktiv lungesygdom

Country Status (23)

Country Link
US (3) US20150328194A1 (enExample)
EP (1) EP2931275B1 (enExample)
JP (1) JP6346618B2 (enExample)
KR (1) KR20150096400A (enExample)
CN (1) CN104869996A (enExample)
AR (1) AR094063A1 (enExample)
AU (1) AU2013363837A1 (enExample)
CA (1) CA2892928A1 (enExample)
CY (1) CY1125541T1 (enExample)
DK (1) DK2931275T3 (enExample)
ES (1) ES2917879T3 (enExample)
HR (1) HRP20221034T1 (enExample)
HU (1) HUE059569T2 (enExample)
IL (1) IL239245A0 (enExample)
LT (1) LT2931275T (enExample)
PL (1) PL2931275T3 (enExample)
PT (1) PT2931275T (enExample)
RS (1) RS63476B1 (enExample)
SI (1) SI2931275T1 (enExample)
SM (1) SMT202200303T1 (enExample)
TW (1) TW201427660A (enExample)
UY (1) UY35196A (enExample)
WO (1) WO2014095663A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3299971B2 (ja) 1995-06-21 2002-07-08 アスタ メディカ アクチエンゲゼルシャフト 一体的に形成された調量装置を備えた薬用粉末カートリッジおよび粉末薬剤吸入器
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
ES2195785B1 (es) 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2232306B1 (es) 2003-11-10 2006-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2251866B1 (es) 2004-06-18 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2251867B1 (es) 2004-06-21 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
RU2413544C2 (ru) 2004-07-16 2011-03-10 Алмиралл, С.А. Ингалятор и картридж для лекарственного порошкового препарата и способ работы ингалятора
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors

Also Published As

Publication number Publication date
US20160331733A1 (en) 2016-11-17
IL239245A0 (en) 2015-07-30
EP2931275B1 (en) 2022-06-01
US20180000798A1 (en) 2018-01-04
CN104869996A (zh) 2015-08-26
TW201427660A (zh) 2014-07-16
LT2931275T (lt) 2022-06-27
PT2931275T (pt) 2022-06-30
KR20150096400A (ko) 2015-08-24
JP2016502992A (ja) 2016-02-01
RS63476B1 (sr) 2022-08-31
AU2013363837A1 (en) 2015-06-11
JP6346618B2 (ja) 2018-06-20
CA2892928A1 (en) 2014-06-26
HUE059569T2 (hu) 2022-11-28
SMT202200303T1 (it) 2022-09-14
EP2931275A1 (en) 2015-10-21
AR094063A1 (es) 2015-07-08
HRP20221034T1 (hr) 2022-11-11
US20150328194A1 (en) 2015-11-19
PL2931275T3 (pl) 2022-09-05
ES2917879T3 (es) 2022-07-12
WO2014095663A1 (en) 2014-06-26
UY35196A (es) 2014-07-31
SI2931275T1 (sl) 2022-07-29
CY1125541T1 (el) 2026-02-25

Similar Documents

Publication Publication Date Title
EP2913047A4 (en) Pulmonary disease-specific therapeutic agent
DK2555710T3 (da) Transkateterafgivelsessystem til prostetisk hjerteventil med genindfangningsegenskab
GB2503843B (en) Interface comprising a rolling nasal bridge portion
IL237021B (en) Pharmaceutical composition for treatment of pulmonary arterial hypertension with mesenchymal stem cells
EP2692387A4 (en) CATHETER ARRANGEMENT
EP2752667A4 (en) AUTO ANALYZER
HUE046540T2 (hu) Vírusreplikáció-gátló szerek
BR302012003240S1 (pt) Configuração aplicada em filtro duplo
DK2621603T3 (da) Dåsefiltersystem med et udløb, som samvirker med et filterorgan
DE102011001811A8 (de) Stuhl
LT2768859T (lt) Il17c antagonistai, skirti uždegiminių ligų gydymui
DK2780369T3 (da) Anti-adrenomedullin (adm)-antistof eller anti-adm-antistoffragment eller anti-adm-non-ig-scaffold til forebyggelse eller reduktion af organdysfunktion eller organsvigt hos en patient med en kronisk eller akut sygdom eller akut tilstand
EP2795480A4 (en) EFFECTIVE SAFEGUARD REPLICATION
BR302012002584S1 (pt) Configuracao aplicada em inalador
PT2772261T (pt) Adsorvente administrado oralmente
EP2720045A4 (en) Autoanalyzer
AP2013006989A0 (en) 9-Ä4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxyÜ-1,4-diazaspiroÄ5,5Üundecane-5-one dimaleate, use thereof as a drug, and productionthereof
PL2818163T3 (pl) Kompozycja do podawania donosowego o ulepszonej stabilności
DK3821891T3 (da) Anvendelse af fk506 til behandlingen af pulmonal arteriel hypertension
BR302012005955S1 (pt) "configuração aplicada a cadeira"
EP2796096A4 (en) MEDICAL PORT
SMT202200303T1 (it) Aclidinio per l’uso nell’aumento dell’attività fisica nella vita quotidiana in un paziente con broncopneumopatia cronica ostruttiva
DE102011051966B8 (de) Stuhl
FI20105023A0 (fi) Tiivistetty suodatin
EP2903699A4 (en) NOSE FILTER